NCT00891397View on ClinicalTrials.gov

Pregabalin Versus Placebo as an Add on for Complex Regional Pain Syndrome (CPRS) of the Upper Limb Managed by Stellate Ganglion Block (The PREGA Study)

NATerminatedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

January 31, 2010

Study Completion Date

October 31, 2010

Conditions
Complex Regional Pain Syndromes
Interventions
DRUG

Pregabalin

Dose of 150mg/day divided in two doses. Increased to 300mg/day then to 600mg/day, always divided in two doses for the day.

OTHER

Placebo

Sugar pill

Trial Locations (1)

L8L 2X2

Hamilton General Hospital, Hamilton

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

collaborator

Hamilton Health Sciences Corporation

OTHER

lead

McMaster University

OTHER

NCT00891397 - Pregabalin Versus Placebo as an Add on for Complex Regional Pain Syndrome (CPRS) of the Upper Limb Managed by Stellate Ganglion Block (The PREGA Study) | Biotech Hunter | Biotech Hunter